Patents by Inventor Robert C. Woodworth

Robert C. Woodworth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant transferrins, transferrin half-molecules and mutants thereof
    Patent number: 8080640
    Abstract: Recombinant transferrin, non-glycosylated recombinant transferrin, transferrin half-molecules and mutant transferrins having altered metal-binding or other properties are described. The recombinant transferrin molecules are expressed in functional form by stable eukaryotic cell lines such as baby hamster kidney cells transformed with an expression vector encoding the recombinant molecule. The recombinant transferrins can be used in metal chelation therapy to bind and clear excess toxic metals in patients suffering from metal overloads or as tissue culture medium supplements or replacements.
    Type: Grant
    Filed: July 8, 2004
    Date of Patent: December 20, 2011
    Assignees: University of Vermont, The University of British Columbia
    Inventors: Walter D. Funk, Robert C. Woodworth, Anne B. Mason, Ross T. A. MacGillivray
  • Recombinant transferrins, transferrin half-molecules and mutants thereof
    Patent number: 6825037
    Abstract: Recombinant transferrin, non-glycosylated recombinant transferrin, transferrin half-molecules and mutant transferrins having altered metal-binding or other properties are described. The recombinant transferrin molecules are expressed in functional form by stable eukaryotic cell lines such as baby hamster kidney cells transformed with an expression vector encoding the recombinant molecule. The recombinant transferrins can be used in metal chelation therapy to bind and clear excess toxic metals in patients suffering from metal overloads or as tissue culture medium supplements or replacements.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 30, 2004
    Assignees: University of Vermont, University of British Columbia
    Inventors: Walter D. Funk, Ross T.A. MacGillivray, Anne B. Mason, Robert C. Woodworth
  • Recombinant transferrins, transferrin half-molecules and mutants thereof
    Patent number: 5986067
    Abstract: Recombinant transferrin, non-glycosylated recombinant transferrin, transferrin half-molecules and mutant transferrins having altered metal-binding or other properties are described. The recombinant transferrin molecules are expressed in functional form by stable eukaryotic cell lines such as baby hamster kidney cells transformed with an expression vector encoding the recombinant molecule. The recombinant transferrins can be used in metal chelation therapy to bind and clear excess toxic metals in patients suffering from metal overloads or as tissue culture medium supplements or replacements.
    Type: Grant
    Filed: December 28, 1993
    Date of Patent: November 16, 1999
    Assignees: The University of Vermont and State Agricultural College, The University of British Columbia
    Inventors: Walter D. Funk, Ross T. A. MacGillivray, Anne B. Mason, Robert C. Woodworth